Grail, Inc. (NASDAQ:GRAL – Get Free Report)’s share price hit a new 52-week high during trading on Thursday . The company traded as high as $25.35 and last traded at $25.28, with a volume of 817260 shares trading hands. The stock had previously closed at $22.64.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on GRAL shares. Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price objective for the company. Guggenheim started coverage on Grail in a research note on Thursday, October 17th. They issued a “neutral” rating for the company. Finally, Wolfe Research started coverage on Grail in a research note on Friday, November 15th. They issued a “peer perform” rating for the company.
View Our Latest Report on GRAL
Grail Stock Up 14.7 %
Grail (NASDAQ:GRAL – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The business had revenue of $28.65 million during the quarter. As a group, equities analysts anticipate that Grail, Inc. will post -65.16 EPS for the current year.
Insider Activity
In other news, CFO Aaron Freidin sold 30,452 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Institutional Trading of Grail
A number of institutional investors have recently made changes to their positions in GRAL. Douglas Lane & Associates LLC acquired a new stake in Grail during the 4th quarter worth about $3,034,000. Slow Capital Inc. acquired a new stake in Grail during the 4th quarter worth about $2,379,000. 180 Wealth Advisors LLC acquired a new stake in Grail during the 4th quarter worth about $1,681,000. Wesbanco Bank Inc. acquired a new stake in Grail during the 4th quarter worth about $523,000. Finally, Exchange Traded Concepts LLC acquired a new stake in Grail during the 4th quarter worth about $507,000.
About Grail
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
- Five stocks we like better than Grail
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Ride Out The Recession With These Dividend Kings
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Stock Analyst Ratings and Canadian Analyst Ratings
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.